GlassScriptPhysician profile
Payman J Danielpour
NPI 1083857122
$17,204.75
in general payments reported to CMS, 2019-2025
13 companies · $7,063 in 2025
The $7,063 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,041 · 2020: $35.37 · 2021: $3,514 · 2022: $240 · 2023: $3,038 · 2024: $274 · 2025: $7,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,750 · Food and Beverage: $1,575 · Travel and Lodging: $1,462 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,750.00 |
| Food and Beverage | $1,575.01 |
| Travel and Lodging | $1,462.43 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $6,804.08 | 2024-2025 | |
| Allergan, INC. | $6,484.04 | 2019-2022 | |
| Abbvie INC. | $3,198.68 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Mentor Worldwide LLC | $138.31 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Vertex Pharmaceuticals Incorporated | $132.72 | 2025 | |
| Lumenis, INC | $121.15 | 2019 | |
| Revance Therapeutics, INC. | $102.01 | 2024 | Daxi, Daxxify |
| Merz North America, INC. | $75.44 | 2019-2021 | |
| Baxter Healthcare | $59.09 | 2025 | Perclot |
| Integra Lifesciences Corporation | $26.68 | 2025 | Integra, Omnigraft, Surgimend |
| Smith+Nephew, INC. | $21.76 | 2022 | |
| Apollo Endosurgery US INC | $21.69 | 2019 | |
| Neuronetics, INC. | $19.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Payman Danielpour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.